Cargando…
Development of a pharmacoeconomic registry: an example using hormonal contraceptives
BACKGROUND: Disease-specific registries, documenting costs and probabilities from pharmacoeconomic studies along with health state utility values from quality-of-life studies could serve as a resource to guide researchers in evaluating the published literature and in the conduct of future economic e...
Autores principales: | White, Annesha, Srinivasan, Meenakshi, Wingate, La Marcus, Peasah, Samuel, Fleming, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981865/ https://www.ncbi.nlm.nih.gov/pubmed/33745016 http://dx.doi.org/10.1186/s13561-021-00309-z |
Ejemplares similares
-
Incorporating Pharmacometrics into Pharmacoeconomic Models: Applications from Drug Development
por: Srinivasan, Meenakshi, et al.
Publicado: (2020) -
Quantifying the economic burden of unintended pregnancies due to drug–drug interactions with hormonal contraceptives from the United States payer perspective
por: Srinivasan, Meenakshi, et al.
Publicado: (2021) -
Antiseizure medications and oral contraceptives: Impact of enzyme inducers on pregnancy outcomes and costs
por: Anderson, Seri, et al.
Publicado: (2021) -
Development of pharmacoeconomics guidelines for India
por: Thomas, Dixon, et al.
Publicado: (2014) -
Essentials of pharmacoeconomics
por: Rascati, Karen L.
Publicado: (2014)